Significance of Coexpression of Urokinase-type Plasminogen Activator, and Matrix Metalloproteinase 3 (Stromelysin) and 9 (Gelatinase B) in Colorectal Carcinoma
- 31 October 2000
- journal article
- Published by Elsevier in Journal of Surgical Research
- Vol. 93 (2) , 211-218
- https://doi.org/10.1006/jsre.2000.5952
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Molecular Cloning and Characterization of Human Tissue Inhibitor of Metalloproteinase 4Journal of Biological Chemistry, 1996
- Steps Involved in Activation of the Pro-matrix Metalloproteinase 9 (Progelatinase B)-Tissue Inhibitor of Metalloproteinases-1 Complex by 4-Aminophenylmercuric Acetate and ProteinasesJournal of Biological Chemistry, 1995
- Furin-dependent intracellular activation of the human stromelysin-3 zymogenNature, 1995
- A matrix metalloproteinase expressed on the surface of invasive tumour cellsNature, 1994
- Production of matrix metalloproteinases and tissue inhibitor of metalloproteinases-1 by human brain tumorsJournal of Neurosurgery, 1994
- Cloning of the cDNA Encoding Human Tissue Inhibitor of Metalloproteinases-3 (TIMP-3) and Mapping of the TIMP3 Gene to Chromosome 22Genomics, 1994
- Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) is induced in rabbit articular chondrocytes by cotreatment with interleukin 1β and a protein kinase C activatorExperimental Cell Research, 1992
- A prospective clinicopathologic study of venous invasion in golorectal cancerThe American Journal of Surgery, 1991
- Influence of Organ Environment on Extracellular Matrix Degradative Activity and Metastasis of Human Colon Carcinoma CellsJNCI Journal of the National Cancer Institute, 1990
- The pathogenesis of cancer metastasisNature, 1980